Published: Thu, May 10, 2018
Medicine | By Douglas Stevenson

USPSTF: Final Recommendation Statement on Prostate Cancer Screening

USPSTF: Final Recommendation Statement on Prostate Cancer Screening

The government-appointed U.S. Preventive Services Task Force had earlier opposed routine screening. The organization has been a steadfast proponent of screening for early detection that is not exclusively limited to the PSA test and provides education on other screening methods, genomic testing and prostate cancer biomarkers that help individualize patient care and treatment choices.

A man's lifetime risk of being diagnosed with prostate cancer is about 13 percent, but the lifetime risk of dying of prostate cancer is only 2.5 percent, with half of those deaths occurring at age 80 or beyond, the Task Force authors note in their recommendation statement published on Tuesday in JAMA.

Men aged 55 to 69 should have the right to be screened for prostate cancer, according to revised USA guidance that highlights a hard decision faced by millions in Britain. The guidance doesn't apply to men younger than 55 because they are considered low risk. However, with regard to older patients ( 70 years), the AUA stated that "select older, healthier men may garner a benefit" from PSA screening. "Prostate cancer is almost 100 percent survivable if caught early and screening is the best way to do that".

With the new recommendation, doctors should help with the decision-making process by providing patients with information.

The NHS has never recommended screening because interventions for the high numbers of false positives can make men impotent or incontinent. But researchers have found that testing for the prostate-specific antigen can save lives. In determining whether this service is appropriate in individual cases, patients and clinicians should consider the balance of benefits and harms on the basis of family history, race/ethnicity, comorbid medical conditions, patient values about the benefits and harms of screening and treatment-specific outcomes, and other health needs. These men would be the best candidates for screening.

Like this: